These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3059592)

  • 1. Blood transfusion and tumor growth.
    Tartter PI; Francis DM
    Transplant Proc; 1988 Dec; 20(6):1108-11. PubMed ID: 3059592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of perioperative blood transfusion on prostate cancer recurrence.
    Ford BS; Sharma S; Rezaishiraz H; Huben RS; Mohler JL
    Urol Oncol; 2008; 26(4):364-7. PubMed ID: 18367097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies.
    McAlister FA; Clark HD; Wells PS; Laupacis A
    Br J Surg; 1998 Feb; 85(2):171-8. PubMed ID: 9501809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset N0) non-oat cell lung cancer.
    Tartter PI; Burrows L; Kirschner P
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):659-62. PubMed ID: 6492836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the timing of blood transfusion on experimental tumor growth.
    Francis DM; Clunie GJ
    J Surg Res; 1993 Mar; 54(3):237-41. PubMed ID: 8474239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous blood donation and epoetin alfa in cancer surgery.
    Jeekel J
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):43-6; discussion 47. PubMed ID: 8723582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group.
    Mynster T; Christensen IJ; Moesgaard F; Nielsen HJ
    Br J Surg; 2000 Nov; 87(11):1553-62. PubMed ID: 11091245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of transfusion on immune function. Cancer recurrence and infection.
    Blumberg N; Heal JM
    Arch Pathol Lab Med; 1994 Apr; 118(4):371-9. PubMed ID: 8166587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible association between survival time and transfusion in cervical cancer.
    Blumberg N; Agarwal MM; Chuang C
    Yale J Biol Med; 1988; 61(6):493-500. PubMed ID: 3242314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival advantage of using autologous blood transfusion during surgery for esophageal cancer.
    Motoyama S; Saito R; Kamata S; Kitamura M; Okuyama M; Imano H; Nakamura M; Suzuki H; Omokawa S; Motohashi Y; Ogawa J
    Surg Today; 2002; 32(11):951-8. PubMed ID: 12444430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic aspects of blood transfusion.
    Klein HG
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):16-20. PubMed ID: 8202721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative blood transfusion has prognostic significance for breast cancer.
    Tartter PI; Burrows L; Papatestas AE; Lesnick G; Aufses AH
    Surgery; 1985 Feb; 97(2):225-30. PubMed ID: 3969625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood transfusion and the risk of recurrence in stage IB cervical cancer.
    Morris PC; Haugen J; Tomjack J; Anderson B; Buller RE
    Gynecol Oncol; 1995 Jun; 57(3):401-6. PubMed ID: 7774845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer.
    Lange MM; van Hilten JA; van de Watering LM; Bijnen BA; Roumen RM; Putter H; Brand A; van de Velde CJ;
    Br J Surg; 2009 Jul; 96(7):734-40. PubMed ID: 19526613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.
    Clark DA; Gorczynski RM; Blajchman MA
    Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A relationship between perioperative blood transfusion and recurrence of carcinoma of the sigmoid colon following potentially curative surgery.
    Creasy TS; Veitch PS; Bell PR
    Ann R Coll Surg Engl; 1987 May; 69(3):100-3. PubMed ID: 3605994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of blood transfusions on recurrence and survival after rectal cancer surgery.
    Jagoditsch M; Pozgainer P; Klingler A; Tschmelitsch J
    Dis Colon Rectum; 2006 Aug; 49(8):1116-30. PubMed ID: 16779711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of transfusion-associated immunosuppression.
    Blajchman MA; Bordin JO
    Curr Opin Hematol; 1994 Nov; 1(6):457-61. PubMed ID: 9371323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic transfusion and infection: economic and clinical implications.
    Blumberg N
    Semin Hematol; 1997 Jul; 34(3 Suppl 2):34-40. PubMed ID: 9253782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.